10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2016

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from __________________

Commission file number:  333-193725

AMERICAN BREWING COMPANY, INC.

(Exact name of registrant as specified in its charter)

Washington	27-2432263
(State or other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

3625 Del Amo Boulevard, Suite 385 Torrance, CA	90503
(Address of Principal Executive Offices)	(Zip Code)

(888) 240-9197

(Registrant's telephone number, including area code)

None

(Former Name or Former Address, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☑  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☐  No ☑

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer   ☐	Accelerated filer   ☐
Non-accelerated filer   ☐	Smaller reporting company   ☑
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☑.

As of May 6, 2016, there were 15,435,651 shares of registrant's common stock outstanding.

- 1 -

AMERICAN BREWING COMPANY, INC.

FORM 10-Q

FOR THE THREE MONTHS ENDED MARCH 31, 2016

TABLE OF CONTENTS

		Page
PART I.  FINANCIAL INFORMATION
ITEM 1	Financial Statements	3
	Balance sheets as of March 31, 2016 and December 31, 2015 (unaudited)	3
	Statements of operations for the three months ended March 31, 2016 (Successor)   and the three months ended March 31, 2015 (Predecessor) (unaudited)	4
	Statements of cash flows for the three months ended March 31, 2016 (Successor)   and the three months ended March 31, 2015 (Predecessor) (unaudited)	5
	Notes to the Unaudited Interim Financial Statements	6
ITEM 2.	Management's Discussion and Analysis of Financial Condition and   Results of Operations	12
ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	19
ITEM 4.	Controls and Procedures	19
PART II.  OTHER INFORMATION		21
ITEM 1.	Legal Proceedings	21
ITEM 1A.	Risk Factors	21
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
ITEM 3.	Defaults Upon Senior Securities	21
ITEM 4.	Mine Safety Disclosures	21
ITEM 5.	Other Information	21
ITEM 6.	Exhibits	22
SIGNATURES		23

- 2 -

PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

AMERICAN BREWING COMPANY, INC.
BALANCE SHEETS
(UNAUDITED)
	March 31, 2016			December 31, 2015
ASSETS
CURRENT ASSETS:
Cash	$	151,115		$	43,856
Accounts receivable, net of allowance for doubtful accounts of zero and zero, respectively		290,064			259,619
Inventories		222,051			196,220
Prepaid expenses and other current assets		5,562			26,264
Total current assets		668,792			525,959
Property and equipment, net of accumulated depreciation of $14,074 and $10,215, respectively		62,477			66,336
Customer relationships, net of accumulated amortization of $83,333 and $62,500, respectively		166,667			187,500
Goodwill		389,014			389,014
Total assets	$	1,286,950		$	1,168,809
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts payable	$	402,100		$	282,845
Factoring payable		112,102			110,663
Accrued expenses and other current liabilities		253,401			177,589
Total current liabilities		767,603			571,097
Convertible note payable, net of unamortized discounts of $17,987and $0, respectively		182,013			-
Note payable, net of unamortized discounts of $113,947 and $121,069, respectively		86,053			78,931
Related party debt, net of unamortized discounts of $34,194 and $36,331, respectively		25,806			23,669
Total liabilities		1,061,475		$	673,697
COMMITMENTS AND CONTINGENCIES		-			-
STOCKHOLDERS' EQUITY:
Common stock, $0.001 par value, 50,000,000 shares authorized;   15,435,651 shares issued and outstanding		15,436			15,436
Series A Preferred stock, $0.001 par value: 250,000 shares   authorized, 250,000 shares issued and outstanding		250			250
Series B Preferred stock, $0.001 par value: 300,000 shares   authorized, 254,807 shares issued and outstanding		255			255
Additional paid-in capital		3,829,203			3,811,049
Accumulated deficit		(3,619,669	)		(3,331,878	)
Total stockholders' equity		225,475			495,112
Total liabilities and stockholders' equity	$	1,286,950		$	1,168,809

See accompanying notes which are an integral part of these unaudited financial statements.

- 3 -

AMERICAN BREWING COMPANY, INC.

STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three months			Three months
	ended			ended
	March 31, 2016			March 31, 2015
	Successor			Predecessor
REVENUES	$	588,800		$	576,863
Less:  Cost of Good Sold		499,481			402,235
GROSS PROFIT		89,319			174,628
OPERATING EXPENSES:
Advertising, promotion and selling		96,221			51,516
General and administrative		169,610			145,469
Legal and professional		81,645			47,371
Total operating expenses		347,476			244,356
LOSS FROM OPERATIONS		(258,157	)		(69,728	)
OTHER INCOME (EXPENSE):
Interest expense		(29,634	)		(2,294	)
Total other income (expense)		(29,634	)		(2,294	)
NET LOSS	$	(287,791	)	$	(72,022	)
NET LOSS PER SHARE - BASIC AND DILUTED:	$	(0.02	)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES   OUTSTANDING - BASIC AND DILUTED		15,435,651

See accompanying notes which are an integral part of these unaudited financial statements.

- 4 -

AMERICAN BREWING COMPANY, INC.

STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Three months			Three months
	ended			ended
	March 31, 2016			March 31, 2015
	Successor			Predecessor
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(287,791	)	$	(72,022	)
Adjustments to reconcile net loss to net cash (used in)   provided by operating activities:
Depreciation		3,859			5,100
Amortization of customer relationships		20,833			-
Amortization of debt discounts		9,426			-
Changes in operating assets and liabilities:
Accounts receivable		(30,445	)		(23,277	)
Inventories		(25,831	)		105,419
Prepaid expenses and other current assets		20,702			5,695
Accounts payable		119,255			(5,158	)
Accrued expenses and other current liabilities		75,812			3,473
Reserve for legal settlement		-			5,100
Net cash (used in) provided by operating activities		(94,180	)		24,330
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		-			(11,688	)
Net cash used in investment activities		-			(11,688	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible note payable		200,000			-
Net factoring advances		1,439			-
Payments on convertible notes payable to related parties		-			(69,000	)
Repayment of notes payable and capital lease obligations		-			(1,874	)
Net cash provided by (used in) financing activities		201,439			(70,874	)
NET CHANGE IN CASH		107,259			(58,232	)
CASH AT BEGINNING OF PERIOD		43,856			125,312
CASH AT END OF PERIOD	$	151,115		$	67,080
SUPPLEMENTAL INFORMATION:
Cash paid during the period for:
Interest	$	-		$	1,861
Income taxes	$	-		$	-
NONCASH INVESTING AND FINANCING ACTIVITIES:
Warrants issued with convertible debt	$	18,154		$	-

See accompanying notes which are an integral part of these unaudited financial statements.

- 5 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

American Brewing Company, Inc. (the "Company") was formed under the laws of the State of Washington on April 26, 2010.  Through September 2015, the Company was a micro-brewing company and also manufactured and sold búcha® Live Kombucha, a gluten free, organic certified, sparkling kombucha tea.  The Company acquired the búcha® Live Kombucha brand and the assets related to the production and sale of it in April 2015.  The búcha® Live Kombucha brand is distributed in major health and grocery chains throughout North America.

On October 1, 2015, the Company sold its assets and various liabilities related to its brewery and micro-brewing operations.  The assets sold consisted of accounts receivable, inventories, prepaid assets and property and equipment.  The liabilities consisted of brewing-related contracts held by the Company, liabilities related to inventory as well as lease obligations.  The Company recognized the sale of its brewery and micro-brewing operations as a discontinued operation in the year ended December 31, 2015.  Since October 2015, the Company is focusing exclusively on its búcha® Live Kombucha business, which produces a gluten-free, organic certified sparkling kombucha tea.

Name change

On March 30, 2016, the board of directors recommended that the Company amend its articles of incorporation to change its name from American Brewing Company, Inc. to Búcha, Inc., and to effect a change to its public stock symbol.  The majority shareholders acting by majority consent approved the name change.  The Company has filed the necessary state and regulatory documents to effect the name change.

Basis of Presentation

The accompanying unaudited interim financial statements as of March 31, 2016 of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules of the Securities and Exchange Commission ("SEC"), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 filed with the SEC on April 7, 2016.  In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein.  The results of operations for interim periods are not necessarily indicative of the results to be expected for future quarters or for the full year.  Notes to the financial statements which substantially duplicate the disclosure contained in the Form 10-K have been omitted.

The accompanying financial statements have been presented on a comparative basis.  For periods after the acquisition of the búcha® Live Kombucha brand (since April 1, 2015), our financial results are referred to as Successor.  For periods prior to the acquisition of the búcha® Live Kombucha brand, our financial results are referred to as Predecessor.  Where applicable, a black line separates the Successor and Predecessor financial information to highlight the lack of comparability between the periods.

Concentrations

Receivables arising from sales of the Company's products are not collateralized.  As of March 31, 2016, three customers represented approximately 58.1% (35.6%, 12.2% and 10.3%) of accounts receivable and as of December 31, 2015, three customers represented approximately 92.8% (59.0%, 22.9% and 10.9%) of accounts receivable.  For the three months ended March 31, 2016 (Successor), two customers represented approximately 60.2% (42.4% and 17.8%) of revenue.  For the three months ended March 31, 2015 (Predecessor), three customers represented approximately 85.6% (30.2%, 29.4% and 26.0%) of revenue.

- 6 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Accounts Receivable Factoring Arrangement with Recourse

In April 2015, the Company entered into a factoring agreement to sell, with recourse, certain receivables to an unrelated third-party financial institution.  Under the terms of the factoring agreement, the Company receives an advance of 80% of qualified receivables and maximum amount of outstanding advances at any one time will not exceed $500,000.  For the three months ended March 31, 2016 (Successor), the Company received additional net advances from the factoring of accounts receivable of $1,439 and recognized factoring interest and fees of $13,657.  The Company pays factoring fees associated with the sale of receivables at the rate of 0.67% of the gross face value of the receivable for every ten-day period or fraction thereof from the date of the advance until the receivable is paid in full.  The outstanding factoring payable as of March 31, 2016 and December 31, 2015 was $112,102 and $110,663, respectively.

Goodwill

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair value of the identifiable net assets acquired.  In accordance with SFAS No. 142, Goodwill and Other Intangible Assets, goodwill and other intangibles with indefinite useful lives are not amortized but tested for impairment annually or more frequently when events or circumstances indicates that the carrying value of a reporting unit more likely than not exceeds its fair value.  The goodwill impairment test is applied by performing a qualitative assessment before calculating the fair value of the reporting unit.  If, on the basis of qualitative factors, it is considered not more likely than not that the fair value of the reporting unit is less than the carrying amount, further testing of goodwill for impairment would not be required.  Otherwise, goodwill impairment is tested using a two-step approach.

Intangible assets are recorded at acquisition cost less accumulated amortization and impairment.  Definite lived intangible assets are amortized over their estimated useful life using the straight-line method, which is determined by identifying the period over which the cash flows from the asset are expected to be generated.

Long-lived Assets

Our long-lived assets consisted of property and equipment and customer relationships and are reviewed for impairment in accordance with the guidance of the FASB Topic ASC 360, Property, Plant, and Equipment. We test for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Through March 31, 2016, we had not experienced impairment losses on its long-lived assets as management determined that there were no indicators that a carrying amount of the asset may not be recoverable.

NOTE 2 – GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business.  The Company had an accumulated deficit of $3,619,669 and $3,331,878 as of March 31, 2016 and December 31, 2015, respectively, had net losses of $287,791 and $72,022 for the three months ended March 31, 2016 (Successor), and for the three months ended March 31, 2015 (Predecessor), respectively, and had negative working capital of $98,811 as of March 31, 2016.  These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern.

- 7 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

While the Company is attempting to increase sales and generate additional revenues, the Company's cash position may not be significant enough to support the Company's daily operations.  During the three months ended March 31, 2016, the Company borrowed $200,000 in the form of a Convertible Promissory Note, which included warrants (See Note 6), however the Company needs additional financing.  If the Company is unable to obtain additional financing through the issuance of debt or equity, the Company may be unable to continue as a going concern.  While the Company believes in the viability of its strategy to generate additional revenues and in its ability to raise additional funds, there can be no assurances to that effect.  The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

NOTE 3 – INVENTORIES

Inventories consist of brewing materials, tea ingredients, bulk packaging and finished goods.  The cost elements of work in process and finished goods inventory consist of raw materials and direct labor.  Provisions for excess inventory are included in cost of goods sold and have historically been immaterial but adequate to provide for losses on its raw materials.  Inventories are stated at the lower of cost, determined on the first-in, first-out basis, or market.

Inventories consisted of the following as of:

	March 31, 2016		December 31, 2015
Raw materials	$	99,105	$	46,928
Work-in-process		20,192		5,798
Finished goods		102,754		143,494
	$	222,051	$	196,220

NOTE 4 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following as of:

	March 31, 2016			December 31, 2015
Property and equipment	$	76,551		$	76,551
Less: accumulated depreciation		(14,074	)		(10,215	)
	$	62,477		$	66,336

Depreciation expense is computed on the basis of three to five year useful lives for all property and equipment.  Depreciation expense was $3,859 and $5,100 for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.

- 8 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 5 – CUSTOMER RELATIONSHIPS

Customer relationships consisted of the following as of:

	March 31, 2016			December 31, 2015
Customer relationships	$	250,000		$	250,000
Less: accumulated amortization		(83,333	)		(62,500	)
	$	166,667		$	187,500

Customer relationships were evaluated as part of the tangible and intangible assets acquired in the acquisition of the búcha® Live Kombucha brand and recorded at their fair market value.  Amortization expense is computed on a straight-line basis of three years determined to be the useful life.  Amortization expense was $20,833 and $ -0- for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.  Amortization expense is classified as cost of goods sold in the statements of operations.

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following as of:

	March 31, 2016		December 31, 2015
Notes payable, net of unamortized discounts of $113,947 and $121,069	$	86,053	$	78,931
Convertible promissory note, net of unamortized discounts of $17,987 and zero		182,013		-
		268,066		78,931
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $131,934 and $121,069	$	268,066	$	78,931

In March 2015, the Company borrowed $200,000.  The note bears interest at 10% per annum and is due and payable beginning December 31, 2015 maturing on March 31, 2020.  Payments of interest are required quarterly.  Should the Company be successful in raising $2,000,000 or more in funding, then the entire balance of the note will be due immediately.  The note was issued in conjunction with an equity payment totaling 176,734 shares of Series B preferred stock that was issued with the debt.  The Company has allocated the loan proceeds among the debt and the stock based upon relative fair value.  The relative fair value of the stock was determined to be $142,434 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $200,000 ($86,053 net of the unamortized discount.)

On March 19, 2016, the Company entered into a Securities Purchase Agreement with an unaffiliated third party, whereby the Company sold a Convertible Promissory Note in an amount of $200,000.  The purchaser also received a three-year Warrant to purchase 100,000 shares at an exercise price of $0.40 per share.  The Convertible Promissory Note is convertible after 180 days into shares of the Company's common stock at a twenty-five percent (25%) discount to the Volume Weighted Average Price for the five (5) trading days prior to the date of conversion.  The Company has allocated the loan proceeds among the debt and the warrant based upon relative fair value.  The relative fair value of the warrant was determined to be $18,154 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $200,000 ($182,013 net of the unamortized discount.)

- 9 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 7 – RELATED PARTY DEBT

Related party debt consisted of the following as of:

	March 31, 2016		December 31, 2015
Related party debt, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669

In March 2015, the Company borrowed $60,000 from a member of management.  The note bears interest at 10% per annum and is due and payable beginning June 30, 2015 maturing on March 31, 2020.  Payments of interest are required quarterly.  Should the Company be successful in raising $2,000,000 or more in funding the entire balance of the note will be due immediately.  The note was issued in conjunction with an equity payment totaling 53,073 shares of Series B preferred stock that was issued with the debt.  The Company has allocated the loan proceeds among the debt and the stock based upon relative fair value.  The relative fair value of the stock was determined to be $42,742 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $60,000 ($25,806 net of the unamortized discount.)

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Operating Lease Commitments

In April 2015, the Company assumed a facilities lease with a third party for the manufacture of its búcha® Live Kombucha tea, which expired February 29, 2016.  In September 2015, the Company extended the facilities lease for 39 months effective March 1, 2016 and expiring May 31, 2019.  The monthly base rent is $2,795 for first 12 months, $2,879 for next 12 months, $2,965 for next 12 months, and $3.054 for the balance of the term.  Monthly rent payments also include common area maintenance charges, taxes, and other charges.

Future minimum lease payments under this facilities lease are approximately as follows:

2016	$	25,155
2017		34,379
2018		35,410
2019		15,093
2020		-
	$	110,037

Rent expense was $7,589 and $6,435 for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.

- 10 -

AMERICAN BREWING COMPANY, INC.

NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)

Legal

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business.  Such matters are subject to many uncertainties, and outcomes are not predictable with assurance.  There are no such matters that are deemed material to the financial statements as of March 31, 2016.

NOTE 9 – STOCKHOLDERS' EQUITY

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock, each having a par value of $0.001, with voting, distribution, dividend and redemption rights, and liquidation preferences and conversions as designated by the board of directors.  The board of directors has designated 250,000 shares as Series A Preferred stock, par value $.001 per share ("Series A Preferred").  Each share of Series A Preferred shall have 500 votes for any election or other vote placed before the shareholders of the Company.  As of March 31, 2016, 250,000 shares of Series A Preferred are issued and outstanding.  The board of directors has designated 300,000 shares as Series B Preferred stock, par value $.001 per shares ("Series B Preferred").  The Series B Preferred is non-voting, not eligible for dividends and ranks equal to common stock and below Series A preferred stock.  Each share of Series B Preferred has a conversion rate into eight shares of common stock.  As of March 31, 2016, 254,807 shares of Series B Preferred are issued and outstanding.

Common Stock

There were no new issuances of common stock during the three months ended March 31, 2016.  As of March 31, 2016, 15,435,651 shares of common stock are issued and outstanding.

NOTE 10 – COMMON STOCK WARRANTS

As of March 31, 2016, the Company had warrants to purchase 1,227,000 shares of common stock outstanding, with exercise prices between $0.40 and $1.00 and expiration dates between April 2016 and October 2019.  A summary of common stock warrants activity for the three months ended March 31, 2016 is as follows:

			Weighted Average
	Number		Exercise Price
Warrants outstanding December 31, 2015		1,127,000	$	0.94
Granted		100,000		0.40
Exercised		-		-
Forfeited		-		-
Warrants outstanding March 31, 2016		1,227,000	$	0.90
Warrants exercisable as of March 31, 2016		1,227,000	$	0.90

During the three months ended March 31, 2016, the Company issued a three-year Warrant to purchase 100,000 shares at an exercise price of $0.40 per share in connection with a $200,000 Convertible Promissory Note (see Note 6).

- 11 -

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Notice Regarding Forward Looking Statements

This Management's Discussion and Analysis of Financial Condition and Results of Operations includes a number of forward-looking statements that reflect management's current views with respect to future events and financial performance.  Forward-looking statements are projections in respect of future events or our future financial performance.  In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other comparable terminology.  Those statements include statements regarding the intent, belief or current expectations of us and members of our management team as well as the assumptions on which such statements are based.  Such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.Forward-looking statements made in this Quarterly Report on Form 10-Q includes statements about:

· our plans to identify and acquire products that we believe will be prospective for acquisition and development;

· concentration of our customer base and fulfillment of existing customer contracts;

· our ability to maintain pricing;

· the cyclical nature of the beverage industry, in particular the Kombucha tea business;

· deterioration of the credit markets;

· our ability to raise additional capital to fund future capital expenditures;

· increased vulnerability to adverse economic conditions due to indebtedness;

· our identifying, making and integrating acquisitions;

· our ability to obtain raw materials and specialized equipment;

· technological developments or enhancements;

· loss of key executives;

· the ability to employ skilled and qualified workers;

· costs and liabilities associated with environmental, health and safety laws, including any changes in the interpretation or enforcement thereof;

· our beliefs regarding the future of our competitors;

· our expectation that the demand for our products will eventually increase; and

· our expectation that we will be able to raise capital when needed.

These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors" set forth in our Annual Report Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission ("SEC") on April 7, 2016, any of which may cause our Company's or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the SEC.  The following Management's Discussion and Analysis of Financial Condition and Results of Operations of the Company should be read in conjunction with the unaudited interim financial statements and notes related thereto included in this Form 10-Q.  We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in the future operating results over time except as required by law.  We believe that our assumptions are based upon reasonable data derived from and known about our business and operations.  No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions.

As used in this Form 10-Q and unless otherwise indicated, the terms "we," "us," "our," or the "Company" refer to American Brewing Company, Inc.  Unless otherwise specified, all dollar amounts are expressed in United States dollars.

- 12 -

Overview

American Brewing Company, Inc. (the "Company") was formed under the laws of the State of Washington on April 26, 2010.  Through September 2015, we were a micro-brewing company and also manufactured and sold búcha® Live Kombucha, a gluten free, organic certified, sparkling kombucha tea.  We acquired the búcha® Live Kombucha brand and the assets related to the production and sale of it in April 2015.  The búcha® Live Kombucha brand is distributed in major health and grocery chains throughout North America.

On October 1, 2015, we sold the assets and various liabilities related to our brewery and micro-brewing operations.  The assets sold consisted of accounts receivable, inventories, prepaid assets and property and equipment.  The liabilities consisted of brewing-related contracts we held, liabilities related to inventory as well as lease obligations.  We recognized the sale of the brewery and micro-brewing operations as a discontinued operation in the year ended December 31, 2015, in accordance with accounting guidelines.

Since October 1, 2015, we have been focusing on integrating the búcha® Live Kombucha business, strengthening the businesses foundation and processes, and positioning the Company as a standalone healthy functional beverage company.  Our búcha® Live Kombucha is an organic certified, probiotic, sparkling kombucha tea.

Our kombucha tea is brewed at our co-packaging facility located at 9 Minson Way, Montebello, CA  90640.  Our headquarters are located at 3625 Del Amo Boulevard, Suite 385, Torrance, CA 90503 (888) 240-9197.  We consider that our current principal office space arrangement is adequate and we will reassess our needs based upon our future growth.  Our fiscal year end is December 31st.

Successor and Predecessor Financial Presentation

Throughout the financial statements and in this MD&A, we refer to Successor and Predecessor.  For periods after the acquisition of the búcha® Live Kombucha brand (since April 1, 2015), our financial results are referred to as Successor.  For periods prior to the acquisition of the búcha® Live Kombucha brand, our financial results are referred to as Predecessor.  Where tables are presented in this MD&A, a black line separates the Successor and Predecessor financial information to highlight the lack of comparability between the periods.

Revenue Model and Distribution Methods of our Products and Services

Our revenue model is based on selling and marketing consumer preferred healthy-functional beverages sold primarily at food, drug, mass, and specialty health retail outlets in the United States.  We develop, market and sell a current portfolio of products, continually innovate with new flavors and products, distribute those products and actively engage in customer relationship development, and market to connect with end consumers.  Currently, our búcha^® Live Kombucha consists of ten flavors including Blood Orange, Grapefruit Sage, Guava Mango, Lemongrass Ginger, Raspberry Pomegranate, Verbena Rose, Yuzu Lemon, and the newest flavors of Elderflower Green Tea, Lemon-Lime/Ginger and Tropical Honey Blossom/Ginger.   We plan to continually innovate and lead the category with new consumer-preferred and trending flavor combinations.

Our búcha^® Live Kombucha is currently distributed into approximately 2,000 stores, consisting of specialty health food stores and food, drug and mass chains including Whole Foods, Kroger, Safeway, PCC, Vons and Ralph's among others.  In the past quarter, distribution has expanded to new outlets by more than 10% versus the previous base, with no losses in distribution with any customers.  In addition to gaining significant new direct distribution, we have also expanded our broker network and coverage in the quarter to now include all major US markets and expect to begin to see the impacts by the end of the year.  Early results have been excellent with the network gaining authorization at Jewel in Illinois, a leading banner of the 2,200 store Albertson's group, the 2nd largest grocery retailer in the United States.  This authorization accelerated the relationship with KeHE Distributors which will open more doors for our products.  Additionally, our Northeast broker partner gained authorization with Shaw's in a five state area in the Northeast and shipments have also already begun to this 132 store group as well.

- 13 -

Búcha^® Live Kombucha products are 100% organic, all natural, fermented black teas made with purified water, organic cane juice, and kombucha culture with origins in China tracing back more than 2,000 years.  Kombucha products contain a colony of bacteria and yeast with more than 1 billion microorganisms.  The product end result is rich in probiotics, B-Vitamins and other nutritional ingredients.  Health benefits are mostly anecdotal but reputed to support digestion, detoxification, and boosting overall immunity.  We believe that our búcha^® Live Kombucha flavor combinations and proprietary production process contribute to an industry leading flavor profile that meets core kombucha-user needs, but also has broad-based mainstream consumer appeal without the typical vinegar aftertaste associated with competitive kombucha products.

Recent Corporate Developments

Effective March 24, 2016, our Chief Executive Officer and President, Neil Fallon, was promoted to serve as Executive Chairman of the board of directors.  Also on this same date, Brent Willis was appointed to serve as Interim Chief Executive Officer, Interim Chief Financial Officer and Director.

On March 30, 2016, our board of directors recommended that the Company amend its articles of incorporation to change its name from American Brewing Company, Inc. to Búcha, Inc., and to effect a change to its public stock symbol.  The majority shareholders acting by majority consent approved the name change.  We intend to file the necessary state and regulatory documents to effect the name change.

During the three months ended March 31, 2016, the Company borrowed $200,000 in the form of a Convertible Promissory Note, which included warrants, from an unaffiliated third party.   Proceeds from the note were used for inventory to meet customer demand and general working capital needs.

Results of Operations

The remainder of this MD&A discusses our continuing operations of the búcha® Live Kombucha tea business.  As discussed previously, where tables are presented, a black line separates the Successor and Predecessor financial information to highlight the lack of comparability between the periods.  See further discussion above under "Successor and Predecessor Financial Presentation" above.

For the three months ended March 31, 2016 (Successor) compared to the three months ended March 31, 2015 (Predecessor).

	Three months ended March 31, 2016 Successor			Three months ended March 31, 2015 Predecessor
Net revenues	$	588,800		$	576,863
Cost of goods sold		499,481			402,235
Gross Profit		89,319			174,628
Operating expenses		347,476			244,356
Other expenses		29,634			2,294
Net loss	$	(287,791	)	$	(72,022	)

Revenues

Net revenues from the sale of our product (Sales less discounts and MCB chargebacks) for the three months ended March 31, 2016 (Successor) were $588,800, as compared to $576,863 for the three months ended March 31, 2015 (Predecessor), an increase of $11,937, or 2.1%.  Sales of our product actually increased approximately $55,000 for the three months ended March 31, 2016 despite the discontinuation of Costco business.  This sales increase was offset by an approximate $43,000 increase in customer discounts and MCB chargebacks.  Promotional expenses were increased to counter the effects of the Predecessor's cessation of support to the brokers.

- 14 -

Cost of Goods Sold

	Three months ended March 31, 2016 Successor		Three months ended March 31, 2015 Predecessor
Production costs/labor/freight	$	474,789	$	397,135
Depreciation		3,859		5,100
Amortization of customer relationships		20,833		-
Cost of goods sold	$	499,481	$	402,235

Cost of goods sold is comprised of production costs, manufacturing labor, freight and depreciation and amortization.  Total cost of goods sold for the three months ended March 31, 2016 (Successor) was $499,481 as compared to $402,235 for the three months ended March 31, 2015 (Predecessor), an increase of $97,246, or 24.2%.  As a percentage of sales, total cost of goods sold was 84.8% for the three months ended March 31, 2016 (gross margin of 15.2%) compared to 69.7% for the three months ended March 31, 2015 (gross margin of 30.3%).  Production costs, excluding depreciation and amortization, were $474,789 for the three months ended March 31, 2016 (Successor), as compared to $397,135 for the three months ended March 31, 2015 (Predecessor), an increase of $77,654, or 19.6%.  As a percentage of sales, production costs, excluding depreciation and amortization, were 80.6% for the three months ended March 31, 2016 (Successor), as compared to 68.8% for the three months ended March 31, 2015 (Predecessor).

The decrease in the gross margin is due to several factors, primarily related to how we have chosen to account for freight and delivery costs and manufacturing labor in costs of goods sold compared to the accounting by the Predecessor.  Freight and manufacturing labor totaled approximately $124,000 for the three months ended March 31, 2016 (Successor).  A secondary contributing factor included having to absorb all raw material and packaging supply cost increases while not being able to increase sale prices.

One of our goals for 2016 and beyond is to review all opportunities to improve gross margins.  Our búcha® Live Kombucha product is currently produced via a third-party manufacturer in one location in Southern California.  Our glass bottles, raw ingredients and other materials are shipped from the Midwest and other locations.  Finished goods are produced and shipped nationally from the manufacturing location.  This model is suboptimal, and although it may be the same model as the other kombucha manufacturers in the industry, we believe that there are significant opportunities to improve gross margins by reducing supply chain expenses.

Acquisition accounting rules require the evaluation of the tangible and intangible assets acquired in an acquisition with such identifiable assets to be recorded at their fair market value.  Customer relationships were evaluated as part of our acquisition of the búcha® Live Kombucha brand and were determined to have a fair market value of $250,000.  Amortization expense is computed on a straight-line basis of three years determined to be the useful life.  Amortization expense was $20,833 for the three months ended March 31, 2016 (Successor) and is classified as cost of goods sold in the statements of operations.

Operating Expenses

	Three months ended March 31, 2016 Successor		Three months ended March 31, 2015 Predecessor
Advertising, promotion and selling	$	96,221	$	51,516
General and administrative		169,610		146,469
Legal and professional		81,645		47,371
Total operating expenses	$	347,476	$	244,356

Total operating expenses for the three months ended March 31, 2016 (Successor) was $347,476, as compared to $244,356 for the three months ended March 31, 2015 (Predecessor), an increase of $103,120, or 42.2%.  The table below shows the change in the detail line item operating expenses:

- 15 -

	Increase/ (Decrease)
Advertising, promotion and selling	$	44,705
General and administrative		24,141
Legal and professional:
Legal fees		(41,769	)
Professional fees, including audit and accounting		76,043
	$	103,120

Advertising, promotion and selling expenses for the three months ended March 31, 2016 (Successor) were $96,221, as compared to $51,516 for the three months ended March 31, 2015 (Predecessor), an increase of $44,705.  Contributing to the increase for the three months ended March 31, 2016 was higher sales and marketing salaries and payroll related costs by approximately $6,000, higher tradeshow expenses by approximately $10,000, as we attended two major tradeshows during the three months ended March 31, 2016, higher demos and promotional samples by approximately $10,000 and higher broker fees of approximately $19,000.

General and administrative expenses for the three months ended March 31, 2016 (Successor) were $169,610, as compared to $145,469 for the three months ended March 31, 2015 (Predecessor), an increase of $24,141.  Contributing to this increase for the three months ended March 31, 2016 was higher executive salaries and payroll related costs by approximately $36,000 and higher travel costs of approximately $16,000.  These costs were offset by $16,000 less foreign exchange costs and approximately $10,000 less other G&A expenses.

Legal and professional fees are broken out for discussion purposes.  Legal fees for the three months ended March 31, 2016 (Successor) were $2,575, as compared to $44,371 for the three months ended March 31, 2015 (Predecessor), a decrease of $41,769.  This decrease is due primarily to high legal fees in the three months ended March 31, 2015 due to a lawsuit where the Predecessor was the defendant.

Professional fees for the three months ended March 31, 2016 (Successor) were $79,070, as compared to $3,027 for the three months ended March 31, 2015 (Predecessor), an increase of $76,043.  This increase is due to the audit fees of our independent accounting firm of approximately $35,000 and consulting and advisory fees of our CFO advisory firm of approximately $41,000 incurred during the three months ended March 31, 2016.  Accounting and advisory fees were higher than normal due to expanded audit requirements due to our acquisition of the búcha® Live Kombucha brand in April 2015 followed by our subsequent sale of our brewery related assets in October 2015.  The Predecessor incurred no audit related accounting costs in the corresponding three months ended March 31, 2015.

Other Expenses

	Three months ended March 31, 2016 Successor		Three months ended March 31, 2015 Predecessor
Interest expense:
Interest expense	$	6,551	$	2,294
Amortization of debt discount		9,426		-
		15,977		2,294
Factoring interest and fees		13,657		-
Total other expenses	$	29,634	$	2,294

Interest expense for the three months ended March 31, 2016 (Successor) were $29,634, as compared to $2,294 for the three months ended March 31, 2015 (Predecessor), an increase of $27,340.  Interest expense for the three months ended March 31, 2016 is related to three promissory notes with interest of 8-10%.

- 16 -

Amortization of debt discounts on third party and related party debt was $9,426 for the three months ended March 31, 2016 related to the same three promissory notes.  The Company determined the relative fair value of the stock and/or warrants that were issued with the debt and such debt discount is amortized and charged to interest expense over the terms of the loans.

Factoring interest and fees is related to an April 2015 factoring agreement to sell, with recourse, certain receivables to an unrelated third-party financial institution.  Under the terms of the factoring agreement, we receive an advance of 80% of qualified receivables and are subject to the requirement that the maximum amount of outstanding advances at any one time will not exceed $500,000.  For the three months ended March 31, 2016, we recognized factoring interest and fees of $13,657.  We pay factoring fees associated with the sale of receivables at the rate of 0.67% of the gross face value of the receivable for every ten-day period or fraction thereof from the date of the advance until the receivable is paid in full.

Going Concern

In its audited financial statements as of December 31, 2015, the Company was issued an opinion by its auditors that raised substantial doubt about the ability to continue as a going concern based on the Company's current financial position.  Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully develop and market our products and our ability to generate revenues.

Liquidity and Capital Resources

As of March 31, 2016, we had cash of $151,115 compared to cash as of December 31, 2015 of $43,856.

We believe that cash flow from operations will not meet our present and near-term cash needs and thus we will require additional cash resources, including the sale of equity or debt securities, to meet our planned capital expenditures and working capital requirements for the next 12 months.  During the three months ended March 31, 2016, the Company borrowed $200,000 in the form of a Convertible Promissory Note, which included warrants, from an unaffiliated third party.  We estimate that our capital needs over the next twelve months period to be $500,000 to $750,000.  We will require additional cash resources to continue expanding the distribution of our búcha® Live Kombucha brand and to fund our operations.  If our own financial resources and future current cash-flows from operations are insufficient to satisfy our capital requirements, we may seek to sell additional equity or debt securities or obtain additional credit facilities.  Any sale of additional equity securities will result in dilution to our stockholders.  The incurrence of indebtedness will result in increased debt service obligations and could require us to agree to operating and financial covenants that could restrict our operations or modify our plans to grow the business.  Financing may not be available in amounts or on terms acceptable to us, if at all.  Any failure by us to raise additional funds on terms favorable to us, or at all, will limit our ability to expand our business operations and could harm our overall business prospects.

Working Capital

	March 31, 2016			December 31, 2015
Current assets	$	668,792		$	525,959
Less: current liabilities		767,603			571,097
Working capital deficiency	$	(98,811	)	$	(45,138	)

Current assets as of March 31, 2016 (Successor) and March 31, 2015 (Predecessor) primarily relate to $151,115 and $43,856 in cash, $290,064 and $259,619 in accounts receivable and $222,051 and $196,220 in inventory, respectively.

Current liabilities as of March 31, 2016 (Successor) and March 31, 2015 (Predecessor) primarily relate to $402,100 and $282,845 in accounts payable, $253,401 and $177,589 for accrued expenses and $112,102 and $110,663 for factoring payable, respectively.

- 17 -

Cash Flows

	Three months ended March 31, 2016 Successor			Three months ended March 31, 2015 Predecessor
Net cash (used in) provided by operating activities	$	(94,180	)	$	24,330
Net cash used in investing activities		-			(11,688	)
Net cash provided by (used in) financing activities		201,439			(70,874	)
Net increase (decrease) in cash	$	107,259		$	(58,232	)

Operating Activities

Net cash used in operating activities for the three months ended March 31, 2016 (Successor) was $94,180, as compared to net cash provided by operating activities of $24,330 for the three months ended March 31, 2015 (Predecessor).

Investing Activities

Net cash used in investing activities for the three months ended March 31, 2016 (Successor) was $-0-, as compared to $11,688 for the three months ended March 31, 2015 (Predecessor).

Financing Activities

Net cash provided by investing activities for the three months ended March 31, 2016 (Successor) was $201,439, as compared to cash used in investing activites of $70,874 for the three months ended March 31, 2015 (Predecessor).  Net cash provided by financing activities was mainly attributable to proceeds from a new borrowing on notes payable of $200,000 during the three months ended March 31, 2016.

Future Financing

We will require additional funds to implement our growth strategy.  Therefore, we will need to raise additional capital to sufficiently support its supply chain and support the distribution of our products in the marketplace.  These funds may be raised through equity financing, debt financing, or other sources, which may result in further dilution in the equity ownership of our shares.  There can be no assurance that additional financing will be available to the company when needed or, if available, that it can be obtained on commercially reasonable terms.  If we are not able to obtain the additional financing on a timely basis should it be required, or generate significant material revenues from operations, we will not be able to meet our other obligations as they become due and we may be be forced to scale down or perhaps even cease operations.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Effects of Inflation

We do not believe that inflation has had a material impact on our business, revenues or operating results during the periods presented.

- 18 -

Critical Accounting Policies and Estimates

Our significant accounting policies are more fully described in the notes to our financial statements included herein for the quarter ended March 31, 2016.

Newly Issued Accounting Pronouncements

We do not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on our financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our interim president and chief executive officer (who is the Company's principal executive officer) and our chief financial officer, treasurer, and secretary (who is the Company's principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.  In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.  The ineffectiveness of our disclosure controls and procedures was due to material weaknesses identified in our internal control over financial reporting, described below.

Management's Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over the Company's financial reporting.  In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act of 2002.  Our management, with the participation of our principal executive officer and principal financial officer has conducted an assessment, including testing, using the criteria in Internal Control – Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") (2013).  Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  This assessment included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation.  Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of March 31, 2016.  The ineffectiveness of the Company's internal control over financial reporting was due to the following material weaknesses which are indicative of many small companies with small staff:

(i) inadequate segregation of duties consistent with control objectives; and

(ii) ineffective controls over period end financial disclosure and reporting processes including a lack of multiple levels of supervision and review.

- 19 -

We believe that the weaknesses identified above have not had any material affect on our financial results.  However, we are currently reviewing our disclosure controls and procedures related to these material weaknesses and expect to implement changes in the next calendar year, including identifying specific areas within our governance, accounting and financial reporting processes to add adequate resources to potentially mitigate these material weaknesses.

Our management will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements.  Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.  All internal control systems, no matter how well designed, have inherent limitations.  Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Changes in Internal Control Over Financial Reporting

Other than the additional accounting consultants we hired in the year ended December 31, 2015 to assist with our internal controls and financial reporting, there were no changes in our internal control over financial reporting during the three months ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.  We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been detected.

- 20 -

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is not currently subject to any legal proceedings.  From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant.  There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company's business, financial condition or results of operations.

ITEM 1A. RISK FACTORS

An investment in the Company's common stock involves a number of very significant risks.  You should carefully consider the risk factors included in the "Risk Factors" section of the Annual Report Form 10-K for the year ended December 31, 2015 filed with the SEC on April 7, 2016,, in addition to other information contained in those reports and in this Form 10-Q in evaluating the Company and its business before purchasing shares of its common stock.  The Company's business, operating results and financial condition could be adversely affected due to any of those risks.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of equity securities during the three months ended March 31, 2016.  However, on March 19, 2016, the Company sold a Convertible Promissory Note in an amount of $200,000 to an unaffiliated third party.  The purchaser also received a three-year Warrant to purchase 100,000 shares at an exercise price of $0.40 per share.  The Convertible Promissory Note is convertible after 180 days into shares of the Company's common stock at a twenty-five percent (25%) discount to the Volume Weighted Average Price for the five (5) trading days prior to the date of conversion.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

- 21 -

ITEM 6. EXHIBITS

The following exhibits required by Item 601 to be filed herewith are incorporated by reference to previously filed documents:

Exhibit Number	Description
31.1	Certification of Chief Executive Officer pursuant to Section 302
31.2	Certification of Chief Financial Officer pursuant to Section 302
32.1	Certification of Chief Executive Officer pursuant to Section 906
32.2	Certification of Chief Financial Officer pursuant to Section 906
101.INS**	XBRL Instance Document
101.SCH**	XBRL Taxonomy Schema
101.CAL**	XBRL Taxonomy Calculation Linkbase
101.DEF**	XBRL Taxonomy Definition Linkbase
101.LAB**	XBRL Taxonomy Label Linkbase
101.PRE**	XBRL Taxonomy Presentation Linkbase

** Furnished herewith. XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

- 22 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

By:  /s/ Brent Willis

Brent Willis

Interim Chief Executive Officer, Interim Chief Financial Officer and Director (Principal Executive Officer)

Date:  May 6, 2016

- 23 -

EX-31.1

Exhibit 31.1

AMERICAN BREWING COMPANY, INC.

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brent Willis, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of American Brewing Company, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
	(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:  /s/ Brent Willis

Brent Willis

Interim Chief Executive Officer (Principal Executive Officer)

Date:  May 6, 2016

EX-31.2

Exhibit 31.2

AMERICAN BREWING COMPANY, INC.

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brent Willis, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of American Brewing Company, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
	(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:  /s/ Brent Willis

Brent Willis

Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Date:  May 6, 2016

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Brent Willis, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)the quarterly report on Form 10-Q of American Brewing Company, Inc. for the period ended March 31, 2016 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of American Brewing Company, Inc.

By:  /s/ Brent Willis

Brent Willis

Interim Chief Executive Officer (Principal Executive Officer)

Date:  May 6, 2016

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Brent Willis, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)the quarterly report on Form 10-Q of American Brewing Company, Inc. for the period ended March 31, 2016 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of American Brewing Company, Inc.

By:  /s/ Brent Willis

Brent Willis

Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Date:  May 6, 2016

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2016	May. 06, 2016
Document And Entity Information
Entity Registrant Name	American Brewing Company, Inc.
Entity Central Index Key	0001579823
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		12,280,454
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2016

XML

BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash	$ 151,115	$ 43,856
Accounts receivable, net of allowance for doubtful accounts of zero and zero, respectively.	290,064	259,619
Inventories	222,051	196,220
Prepaid expenses and other current assets	5,562	26,264
Total current assets	668,792	525,959
Property and equipment, net of accumulated depreciation of $14,074 and $10,215, respectively	62,477	66,336
Customer relationships, net of accumulated amortization of $83,333 and $62,500, respectively	166,667	187,500
Goodwill	389,014	389,014
Total assets	1,286,950	1,168,809
CURRENT LIABILITIES:
Accounts payable	402,100	282,845
Factoring payable	112,102	110,663
Accrued expenses and other current liabilities	253,401	177,589
Total current liabilities	767,603	$ 571,097
Convertible note payable, net of unamortized discounts of $17,987and $0, respectively	182,013
Note payable, net of unamortized discounts of $113,947 and $121,069, respectively	86,053	$ 78,931
Related party debt, net of unamortized discounts of $34,194 and $36,331, respectively	25,806	23,669
Total liabilities	$ 1,061,475	$ 673,697
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Common Stock, $0.001 par value; 40,000,000 shares authorized; 15,419,401 shares issued and outstanding	$ 15,436	$ 15,436
Series A preferred stock, $0.001 par value: 250,000 shares authorized, 250,000 shares issued and outstanding	250	250
Series B Preferred stock, $0.001 par value: 300,000 shares authorized, 254,807 shares issued and outstanding	255	255
Additional paid-in capital	3,829,203	3,811,049
Accumulated deficit	(3,619,669)	(3,331,878)
Total stockholders' equity	225,475	495,112
Total liabilities and stockholders' equity	1,286,950	$ 1,168,809
Series A Preferred Stock [Member]
STOCKHOLDERS' EQUITY:
Series A preferred stock, $0.001 par value: 250,000 shares authorized, 250,000 shares issued and outstanding	250
Series B Preferred Stock [Member]
STOCKHOLDERS' EQUITY:
Series B Preferred stock, $0.001 par value: 300,000 shares authorized, 254,807 shares issued and outstanding	$ 255

XML

BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	50,000,000	50,000,000
Common Stock, shares issued	15,435,651	15,435,651
Common Stock, shares outstanding	15,435,651	15,435,651
Series A Preferred Stock, par value	$ 0.001	$ 0.001
Series A Preferred Stock, shares authorized	250,000	250,000
Series A Preferred Stock, shares issued	250,000	250,000
Series A Preferred Stock, shares outstanding	250,000	250,000
Series B Preferred Stock, par value	$ 0.001	$ 0.001
Series B Preferred Stock, shares authorized	300,000	300,000
Series B Preferred Stock, shares issued	254,807	254,807
Series B Preferred Stock, shares outstanding	254,807	254,807
Series A Preferred Stock [Member]
Series A Preferred Stock, par value	$ 0.001
Series A Preferred Stock, shares authorized	250,000
Series A Preferred Stock, shares issued	250,000
Series A Preferred Stock, shares outstanding	250,000
Series B Preferred Stock [Member]
Series A Preferred Stock, par value	$ 0.001
Series A Preferred Stock, shares authorized	300,000
Series A Preferred Stock, shares issued	254,807
Series A Preferred Stock, shares outstanding	254,807

XML

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Successor [Member]
REVENUES	$ 588,800
Less: Cost of Good Sold	499,481
GROSS PROFIT	89,319
OPERATING EXPENSES:
Advertising, promotion and selling	96,221
General and administrative	169,610
Legal and professional	81,645
Total operating expenses	347,476
LOSS FROM OPERATIONS	(258,157)
OTHER INCOME (EXPENSE):
Interest expense	(29,634)
Total other income (expense)	(29,634)
NET LOSS	$ (287,791)
NET LOSS PER SHARE - BASIC AND DILUTED:	$ (0.02)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED	15,435,651
Predecessor [Member]
REVENUES		$ 576,863
Less: Cost of Good Sold		402,235
GROSS PROFIT		174,628
OPERATING EXPENSES:
Advertising, promotion and selling		51,516
General and administrative		145,469
Legal and professional		47,371
Total operating expenses		244,356
LOSS FROM OPERATIONS		(69,728)
OTHER INCOME (EXPENSE):
Interest expense		(2,294)
Total other income (expense)		(2,294)
NET LOSS		$ (72,022)

XML

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM FINANCING ACTIVITIES:
CASH AT BEGINNING OF PERIOD	$ 43,856
CASH AT END OF PERIOD	151,115
Successor [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	(287,791)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	3,859
Amortization of customer relationships	20,833
Amortization of debt discounts	9,426
Changes in operating assets and liabilities:
Accounts receivable	(30,445)
Inventories	(25,831)
Prepaid expenses and other current assets	20,702
Accounts payable	119,255
Accrued expenses and other current liabilities	$ 75,812
Reserve for legal settlement
Net cash (used in) provided by operating activities	$ (94,180)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment
Net cash used in investment activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible note payable	$ 200,000
Net factoring advances	$ 1,439
Payments on convertible notes payable to related parties
Repayment of notes payable and capital lease obligations
Net cash provided by (used in) financing activities	$ 201,439
NET CHANGE IN CASH	107,259
CASH AT BEGINNING OF PERIOD	43,856
CASH AT END OF PERIOD	$ 151,115
SUPPLEMENTAL INFORMATION:
Cash paid during the period for: Interest
Cash paid during the period for: Income taxes
NONCASH INVESTING AND FINANCING ACTIVITIES:
Warrants issued with convertible debt	$ 18,154
Predecessor [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$ (72,022)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation		$ 5,100
Amortization of customer relationships
Amortization of debt discounts
Changes in operating assets and liabilities:
Accounts receivable		$ (23,277)
Inventories		105,419
Prepaid expenses and other current assets		5,695
Accounts payable		(5,158)
Accrued expenses and other current liabilities		3,473
Reserve for legal settlement		5,100
Net cash (used in) provided by operating activities		24,330
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(11,688)
Net cash used in investment activities		$ (11,688)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible note payable
Net factoring advances
Payments on convertible notes payable to related parties		$ (69,000)
Repayment of notes payable and capital lease obligations		(1,874)
Net cash provided by (used in) financing activities		(70,874)
NET CHANGE IN CASH		(58,232)
CASH AT BEGINNING OF PERIOD		125,312
CASH AT END OF PERIOD		67,080
SUPPLEMENTAL INFORMATION:
Cash paid during the period for: Interest		$ 1,861
Cash paid during the period for: Income taxes
NONCASH INVESTING AND FINANCING ACTIVITIES:
Warrants issued with convertible debt

XML

NOTE 1 - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

American Brewing Company, Inc. (the "Company") was formed under the laws of the State of Washington on April 26, 2010.  Through September 2015, the Company was a micro-brewing company and also manufactured and sold búcha® Live Kombucha, a gluten free, organic certified, sparkling kombucha tea.  The Company acquired the búcha® Live Kombucha brand and the assets related to the production and sale of it in April 2015.  The búcha® Live Kombucha brand is distributed in major health and grocery chains throughout North America.

On October 1, 2015, the Company sold its assets and various liabilities related to its brewery and micro-brewing operations.  The assets sold consisted of accounts receivable, inventories, prepaid assets and property and equipment.  The liabilities consisted of brewing-related contracts held by the Company, liabilities related to inventory as well as lease obligations.  The Company recognized the sale of its brewery and micro-brewing operations as a discontinued operation in the year ended December 31, 2015.  Since October 2015, the Company is focusing exclusively on its búcha® Live Kombucha business, which produces a gluten-free, organic certified sparkling kombucha tea.

Name change

On March 30, 2016, the board of directors recommended that the Company amend its articles of incorporation to change its name from American Brewing Company, Inc. to Búcha, Inc., and to effect a change to its public stock symbol.  The majority shareholders acting by majority consent approved the name change.  The Company has filed the necessary state and regulatory documents to effect the name change.

Basis of Presentation

The accompanying unaudited interim financial statements as of March 31, 2016 of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules of the Securities and Exchange Commission ("SEC"), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 filed with the SEC on April 7, 2016.  In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein.  The results of operations for interim periods are not necessarily indicative of the results to be expected for future quarters or for the full year.  Notes to the financial statements which substantially duplicate the disclosure contained in the Form 10-K have been omitted.

The accompanying financial statements have been presented on a comparative basis.  For periods after the acquisition of the búcha® Live Kombucha brand (since April 1, 2015), our financial results are referred to as Successor.  For periods prior to the acquisition of the búcha® Live Kombucha brand, our financial results are referred to as Predecessor.  Where applicable, a black line separates the Successor and Predecessor financial information to highlight the lack of comparability between the periods.

Concentrations

Receivables arising from sales of the Company's products are not collateralized.  As of March 31, 2016, three customers represented approximately 58.1% (35.6%, 12.2% and 10.3%) of accounts receivable and as of December 31, 2015, three customers represented approximately 92.8% (59.0%, 22.9% and 10.9%) of accounts receivable.  For the three months ended March 31, 2016 (Successor), two customers represented approximately 60.2% (42.4% and 17.8%) of revenue.  For the three months ended March 31, 2015 (Predecessor), three customers represented approximately 85.6% (30.2%, 29.4% and 26.0%) of revenue.

Accounts Receivable Factoring Arrangement with Recourse

In April 2015, the Company entered into a factoring agreement to sell, with recourse, certain receivables to an unrelated third-party financial institution.  Under the terms of the factoring agreement, the Company receives an advance of 80% of qualified receivables and maximum amount of outstanding advances at any one time will not exceed $500,000.  For the three months ended March 31, 2016 (Successor), the Company received additional net advances from the factoring of accounts receivable of $1,439 and recognized factoring interest and fees of $13,657.  The Company pays factoring fees associated with the sale of receivables at the rate of 0.67% of the gross face value of the receivable for every ten-day period or fraction thereof from the date of the advance until the receivable is paid in full.  The outstanding factoring payable as of March 31, 2016 and December 31, 2015 was $112,102 and $110,663, respectively.

Goodwill

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair value of the identifiable net assets acquired.  In accordance with SFAS No. 142, Goodwill and Other Intangible Assets, goodwill and other intangibles with indefinite useful lives are not amortized but tested for impairment annually or more frequently when events or circumstances indicates that the carrying value of a reporting unit more likely than not exceeds its fair value.  The goodwill impairment test is applied by performing a qualitative assessment before calculating the fair value of the reporting unit.  If, on the basis of qualitative factors, it is considered not more likely than not that the fair value of the reporting unit is less than the carrying amount, further testing of goodwill for impairment would not be required.  Otherwise, goodwill impairment is tested using a two-step approach.

Intangible assets are recorded at acquisition cost less accumulated amortization and impairment.  Definite lived intangible assets are amortized over their estimated useful life using the straight-line method, which is determined by identifying the period over which the cash flows from the asset are expected to be generated.

Long-lived Assets

Our long-lived assets consisted of property and equipment and customer relationships and are reviewed for impairment in accordance with the guidance of the FASB Topic ASC 360, Property, Plant, and Equipment. We test for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Through March 31, 2016, we had not experienced impairment losses on its long-lived assets as management determined that there were no indicators that a carrying amount of the asset may not be recoverable.

XML

NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS

NOTE 2 – GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business.  The Company had an accumulated deficit of $3,619,669 and $3,331,878 as of March 31, 2016 and December 31, 2015, respectively, had net losses of $287,791 and $72,022 for the three months ended March 31, 2016 (Successor), and for the three months ended March 31, 2015 (Predecessor), respectively, and had negative working capital of $98,811 as of March 31, 2016.  These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern.

While the Company is attempting to increase sales and generate additional revenues, the Company's cash position may not be significant enough to support the Company's daily operations.  During the three months ended March 31, 2016, the Company borrowed $200,000 in the form of a Convertible Promissory Note, which included warrants (See Note 6), however the Company needs additional financing.  If the Company is unable to obtain additional financing through the issuance of debt or equity, the Company may be unable to continue as a going concern.  While the Company believes in the viability of its strategy to generate additional revenues and in its ability to raise additional funds, there can be no assurances to that effect.  The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

XML

NOTE 3 - INVENTORIES

3 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

INVENTORIES

NOTE 3 – INVENTORIES

Inventories consist of brewing materials, tea ingredients, bulk packaging and finished goods.  The cost elements of work in process and finished goods inventory consist of raw materials and direct labor.  Provisions for excess inventory are included in cost of goods sold and have historically been immaterial but adequate to provide for losses on its raw materials.  Inventories are stated at the lower of cost, determined on the first-in, first-out basis, or market.

Inventories consisted of the following as of:

	March 31, 2016		December 31, 2015
Raw materials	$	99,105	$	46,928
Work-in-process		20,192		5,798
Finished goods		102,754		143,494
	$	222,051	$	196,220

XML

NOTE 4 - PROPERTY AND EQUIPMENT

3 Months Ended

Mar. 31, 2016

Property, Plant and Equipment [Abstract]

NOTE 5 - PROPERTY AND EQUIPMENT

NOTE 4 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following as of:

	March 31, 2016			December 31, 2015
Property and equipment	$	76,551		$	76,551
Less: accumulated depreciation		(14,074	)		(10,215	)
	$	62,477		$	66,336

Depreciation expense is computed on the basis of three to five year useful lives for all property and equipment.  Depreciation expense was $3,859 and $5,100 for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.

XML

NOTE 5 - CUSTOMER RELATIONSHIPS

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

CUSTOMER RELATIONSHIPS

NOTE 5 – CUSTOMER RELATIONSHIPS

Customer relationships consisted of the following as of:

	March 31, 2016			December 31, 2015
Customer relationships	$	250,000		$	250,000
Less: accumulated amortization		(83,333	)		(62,500	)
	$	166,667		$	187,500

Customer relationships were evaluated as part of the tangible and intangible assets acquired in the acquisition of the búcha® Live Kombucha brand and recorded at their fair market value.  Amortization expense is computed on a straight-line basis of three years determined to be the useful life.  Amortization expense was $20,833 and $ -0- for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.  Amortization expense is classified as cost of goods sold in the statements of operations.

XML

NOTE 6 - NOTES PAYABLE

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

NOTES PAYABLE AND CAPITAL LEASES

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following as of:

	March 31, 2016		December 31, 2015
Notes payable, net of unamortized discounts of $113,947 and $121,069	$	86,053	$	78,931
Convertible promissory note, net of unamortized discounts of $17,987 and zero		182,013		-
		268,066		78,931
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $131,934 and $121,069	$	268,066	$	78,931

In March 2015, the Company borrowed $200,000.  The note bears interest at 10% per annum and is due and payable beginning December 31, 2015 maturing on March 31, 2020.  Payments of interest are required quarterly.  Should the Company be successful in raising $2,000,000 or more in funding, then the entire balance of the note will be due immediately.  The note was issued in conjunction with an equity payment totaling 176,734 shares of Series B preferred stock that was issued with the debt.  The Company has allocated the loan proceeds among the debt and the stock based upon relative fair value.  The relative fair value of the stock was determined to be $142,434 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $200,000 ($86,053 net of the unamortized discount.)

On March 19, 2016, the Company entered into a Securities Purchase Agreement with an unaffiliated third party, whereby the Company sold a Convertible Promissory Note in an amount of $200,000.  The purchaser also received a three-year Warrant to purchase 100,000 shares at an exercise price of $0.40 per share.  The Convertible Promissory Note is convertible after 180 days into shares of the Company's common stock at a twenty-five percent (25%) discount to the Volume Weighted Average Price for the five (5) trading days prior to the date of conversion.  The Company has allocated the loan proceeds among the debt and the warrant based upon relative fair value.  The relative fair value of the warrant was determined to be $18,154 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $200,000 ($182,013 net of the unamortized discount.)

XML

NOTE 7 - RELATED PARTY DEBT

3 Months Ended

Mar. 31, 2016

Related Party Transactions [Abstract]

NOTE 7 - RELATED PARTY DEBT

NOTE 7 – RELATED PARTY DEBT

Related party debt consisted of the following as of:

	March 31, 2016		December 31, 2015
Related party debt, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669

In March 2015, the Company borrowed $60,000 from a member of management.  The note bears interest at 10% per annum and is due and payable beginning June 30, 2015 maturing on March 31, 2020.  Payments of interest are required quarterly.  Should the Company be successful in raising $2,000,000 or more in funding the entire balance of the note will be due immediately.  The note was issued in conjunction with an equity payment totaling 53,073 shares of Series B preferred stock that was issued with the debt.  The Company has allocated the loan proceeds among the debt and the stock based upon relative fair value.  The relative fair value of the stock was determined to be $42,742 and was recorded as a debt discount.  The discount will be amortized over the life of the loan to interest expense.  As of March 31, 2016, no payment has been made on this note and the remaining balance of this note is $60,000 ($25,806 net of the unamortized discount.)

XML

NOTE 8 - COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 8 – COMMITMENTS AND CONTINGENCIES

Operating Lease Commitments

In April 2015, the Company assumed a facilities lease with a third party for the manufacture of its búcha® Live Kombucha tea, which expired February 29, 2016.  In September 2015, the Company extended the facilities lease for 39 months effective March 1, 2016 and expiring May 31, 2019.  The monthly base rent is $2,795 for first 12 months, $2,879 for next 12 months, $2,965 for next 12 months, and $3.054 for the balance of the term.  Monthly rent payments also include common area maintenance charges, taxes, and other charges.

Future minimum lease payments under this facilities lease are approximately as follows:

2016	$	25,155
2017		34,379
2018		35,410
2019		15,093
2020		-
	$	110,037

Rent expense was $7,589 and $6,435 for the three months ended March 31, 2016 (Successor) and the three months ended March 31, 2015 (Predecessor), respectively.

Legal

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business.  Such matters are subject to many uncertainties, and outcomes are not predictable with assurance.  There are no such matters that are deemed material to the financial statements as of March 31, 2016.

XML

NOTE 9 - STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2016

Equity [Abstract]

Stockholders' Equity

NOTE 10 – STOCKHOLDERS' EQUITY

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock, each having a par value of $0.001, with voting, distribution, dividend and redemption rights, and liquidation preferences and conversions as designated by the board of directors.

The board of directors has designated 250,000 shares as Series A Preferred stock, par value $.001 per share ("Series A Preferred").  Each share of Series A Preferred shall have 500 votes for any election or other vote placed before the shareholders of the Company.  As of September 30, 2015, 250,000 shares of Series A Preferred are issued and outstanding.

The board of directors has designated 300,000 shares as Series B Preferred stock, par value $.001 per shares ("Series B Preferred").  The Series B Preferred is non-voting, not eligible for dividends and ranks equal to common stock and below Series A preferred stock.  Each share of Series B Preferred has a conversion rate into eight shares of common stock.  During the nine months ended September 30, 2015, the Company issued 229,807 shares of Series B Preferred in conjunction with two promissory notes (see Notes 7 and 8). In June 2015, the Company sold 25,000 shares of Series B Preferred for $25,000 cash. As of September 30, 2015, 254,807 shares of Series B Preferred are issued and outstanding.

Common Stock

The Company is authorized to issue 50,000,000 shares of common stock, $0.001 par value.  During the six months ended September 30, 2015, new issuances of shares of common stock were as follows:

· 1,479,290 shares of common stock were issued pursuant to the Acquisition (see Note 4). The Company estimated the fair market value to be $0.338 per share at the time of issuance. These shares were issued with "Price Protection" for a period of 18 months. If the market value of the common stock issued pursuant to the Acquisition is less than $500,000, the Company shall issue additional shares so the aggregate amount of shares issued in the Acquisition is equal to a market value of $500,000 based on the average closing bid price of the common stock for the five days prior thereto.

· 204,000 shares of common stock were sold to three investors for cash proceeds of $61,200, or $.30 per share, under a private placement offering (the "Offering"). The Offering provided for the issuance warrants to purchase 50% of the number of shares subscribed for, at a price of $.50 per share, expiring one year from the investment. A total of 102,000 warrants were issued and expire between April 13 and June 10, 2016 (see Note 11).

· 52,000 shares of common stock were issued to employees for services rendered. The Company estimated the fair market value to be $0.44 per share at the time of issuance and recorded an expense of $22,880 during the six months ended September 30, 2015.

· 85,714 shares of common stock were issued to employee pursuant to an employment contract whereby the employee would be granted shares of common stock valued at $30,000. The Company estimated the fair market value to be $0.35 per share at the time of issuance and recorded a corresponding expense during the six months ended September 30, 2015.

· 48,177 shares of common stock were issued to employee pursuant to an employment contract whereby the employee would be granted shares of common stock equal to $6,500 at the end of each quarter effective with the three months ending March 31, 2015. The Company estimated the fair market value to be $0.35 per share as of March 31, 2015, $0.46 per share as of June 30, 2015 and $0.42 per shares as of September 30, 2015. Accordingly, the employee received 18,571, 14,130 and 15,476 shares of common stock, respectively, and the Company recorded an expense of $19,500 during the six months ended September 30, 2015.

· 5,000 shares of common stock were issued to Stonefield Fund for services rendered. The Company estimated the fair market value to be $0.44 per share at the time of issuance and recorded an expense of $2,200 during the six months ended September 30, 2015.

· 500,000 shares of common stock were issued to LP Funding, LLC for services rendered. The Company estimated the fair market value to be $0.46 per share at the time of issuance and recorded an expense of $230,000 during the six months ended September 30, 2015.

As of September 30, 2015, 15,419,401 shares of common stock are issued and outstanding.

XML

NOTE 10 - COMMON STOCK WARRANTS

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

COMMON STOCK WARRANTS

NOTE 10 – COMMON STOCK WARRANTS

As of March 31, 2016, the Company had warrants to purchase 1,227,000 shares of common stock outstanding, with exercise prices between $0.40 and $1.00 and expiration dates between April 2016 and October 2019.  A summary of common stock warrants activity for the three months ended March 31, 2016 is as follows:

			Weighted Average
	Number		Exercise Price
Warrants outstanding December 31, 2015		1,127,000	$	0.94
Granted		100,000		0.40
Exercised		-		-
Forfeited		-		-
Warrants outstanding March 31, 2016		1,227,000	$	0.90
Warrants exercisable as of March 31, 2016		1,227,000	$	0.90

During the three months ended March 31, 2016, the Company issued a three-year Warrant to purchase 100,000 shares at an exercise price of $0.40 per share in connection with a $200,000 Convertible Promissory Note (see Note 6).

XML

NOTE 1 - NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited interim financial statements as of March 31, 2016 of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules of the Securities and Exchange Commission ("SEC"), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 filed with the SEC on April 7, 2016.  In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein.  The results of operations for interim periods are not necessarily indicative of the results to be expected for future quarters or for the full year.  Notes to the financial statements which substantially duplicate the disclosure contained in the Form 10-K have been omitted.

The accompanying financial statements have been presented on a comparative basis.  For periods after the acquisition of the búcha® Live Kombucha brand (since April 1, 2015), our financial results are referred to as Successor.  For periods prior to the acquisition of the búcha® Live Kombucha brand, our financial results are referred to as Predecessor.  Where applicable, a black line separates the Successor and Predecessor financial information to highlight the lack of comparability between the periods.

Concentrations

Concentrations

Receivables arising from sales of the Company's products are not collateralized.  As of March 31, 2016, three customers represented approximately 58.1% (35.6%, 12.2% and 10.3%) of accounts receivable and as of December 31, 2015, three customers represented approximately 92.8% (59.0%, 22.9% and 10.9%) of accounts receivable.  For the three months ended March 31, 2016 (Successor), two customers represented approximately 60.2% (42.4% and 17.8%) of revenue.  For the three months ended March 31, 2015 (Predecessor), three customers represented approximately 85.6% (30.2%, 29.4% and 26.0%) of revenue.

Accounts Receivable Factoring Arrangement with Recourse

Accounts Receivable Factoring Arrangement with Recourse

In April 2015, the Company entered into a factoring agreement to sell, with recourse, certain receivables to an unrelated third-party financial institution.  Under the terms of the factoring agreement, the Company receives an advance of 80% of qualified receivables and maximum amount of outstanding advances at any one time will not exceed $500,000.  For the three months ended March 31, 2016 (Successor), the Company received additional net advances from the factoring of accounts receivable of $1,439 and recognized factoring interest and fees of $13,657.  The Company pays factoring fees associated with the sale of receivables at the rate of 0.67% of the gross face value of the receivable for every ten-day period or fraction thereof from the date of the advance until the receivable is paid in full.  The outstanding factoring payable as of March 31, 2016 and December 31, 2015 was $112,102 and $110,663, respectively.

Goodwill

Goodwill

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair value of the identifiable net assets acquired.  In accordance with SFAS No. 142, Goodwill and Other Intangible Assets, goodwill and other intangibles with indefinite useful lives are not amortized but tested for impairment annually or more frequently when events or circumstances indicates that the carrying value of a reporting unit more likely than not exceeds its fair value.  The goodwill impairment test is applied by performing a qualitative assessment before calculating the fair value of the reporting unit.  If, on the basis of qualitative factors, it is considered not more likely than not that the fair value of the reporting unit is less than the carrying amount, further testing of goodwill for impairment would not be required.  Otherwise, goodwill impairment is tested using a two-step approach.

Intangible assets are recorded at acquisition cost less accumulated amortization and impairment.  Definite lived intangible assets are amortized over their estimated useful life using the straight-line method, which is determined by identifying the period over which the cash flows from the asset are expected to be generated.

Long-lived Assets

Long-lived Assets

Our long-lived assets consisted of property and equipment and customer relationships and are reviewed for impairment in accordance with the guidance of the FASB Topic ASC 360, Property, Plant, and Equipment. We test for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Through March 31, 2016, we had not experienced impairment losses on its long-lived assets as management determined that there were no indicators that a carrying amount of the asset may not be recoverable.

XML

NOTE 3 - INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

INVENTORIES

	March 31, 2016		December 31, 2015
Raw materials	$	99,105	$	46,928
Work-in-process		20,192		5,798
Finished goods		102,754		143,494
	$	222,051	$	196,220

XML

NOTE 4 - PROPERTY AND EQUIPMENT (Tables)

3 Months Ended

Mar. 31, 2016

Property, Plant and Equipment [Abstract]

Property and equipment

	March 31, 2016			December 31, 2015
Property and equipment	$	76,551		$	76,551
Less: accumulated depreciation		(14,074	)		(10,215	)
	$	62,477		$	66,336

XML

NOTE 5 - CUSTOMER RELATIONSHIPS (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Customer relationships

	March 31, 2016			December 31, 2015
Customer relationships	$	250,000		$	250,000
Less: accumulated amortization		(83,333	)		(62,500	)
	$	166,667		$	187,500

XML

NOTE 6 - NOTES PAYABLE (Tables)

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Notes Payable and Capital Leases

	March 31, 2016		December 31, 2015
Notes payable, net of unamortized discounts of $113,947 and $121,069	$	86,053	$	78,931
Convertible promissory note, net of unamortized discounts of $17,987 and zero		182,013		-
		268,066		78,931
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $131,934 and $121,069	$	268,066	$	78,931

XML

NOTE 7 - RELATED PARTY DEBT (Tables)

3 Months Ended

Mar. 31, 2016

Related Party Transactions [Abstract]

Related Party debt

	March 31, 2016		December 31, 2015
Related party debt, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669
Less: current portion		-		-
Long-term portion, net of unamortized discounts of $34,194 and 36,331	$	25,806	$	23,669

XML

NOTE 8 - COMMITMENTS AND CONTINGENCIES (Tables)

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Purchase Commitments for each year

2016	$	25,155
2017		34,379
2018		35,410
2019		15,093
2020		-
	$	110,037

XML

NOTE 10 - COMMON STOCK WARRANTS (Tables)

3 Months Ended

Jun. 30, 2015

Notes to Financial Statements

A summary of common stock warrants activity

			Weighted Average
	Number		Exercise Price
Warrants outstanding December 31, 2015		1,127,000	$	0.94
Granted		100,000		0.40
Exercised		-		-
Forfeited		-		-
Warrants outstanding March 31, 2016		1,227,000	$	0.90
Warrants exercisable as of March 31, 2016		1,227,000	$	0.90

XML

NOTE 3 - INVENTORIES (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Note 3 - Inventories Details
Raw materials	$ 99,105	$ 46,928
Work in progress	20,192	5,798
Finished goods	102,754	143,494
Total	$ 222,051	$ 196,220

XML

NOTE 4 - PROPERTY AND EQUIPMENT - Property and equipment (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property and equipment	$ 76,551	$ 76,551
Less: accumulated depreciation	(14,074)	(10,215)
Value after accumulated depreciation	$ 62,477	$ 66,336

XML

NOTE 5 - CUSTOMER RELATIONSHIPS - Customer relationships (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Segment Reporting [Abstract]
Customer relationships	$ 250,000	$ 250,000
Less: accumulated amortization	(83,333)	(62,500)
Customer relationships, accumulated amortization	$ (166,667)	$ (187,500)

XML

NOTE 6 - NOTES PAYABLE (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Note 6 - Notes Payable Details
Notes payable, net of unamortized discounts of $128,191	$ 86,053	$ 78,931
Capital lease obligations	182,013
Subtotal	$ 268,066	$ 78,931
Less current portion, net of unamortized discounts of $40,690 and $0, respectively
Long-term portion, net of unamortized discounts of $185,176 and $0, respectively	$ 268,066	$ 78,931

XML

NOTE 7 - RELATED PARTY DEBT - Related Party debt (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Related Party Transactions [Abstract]
Related party debt, net of unamortized discounts of $34,194 and 36,331	$ 25,806	$ 23,669
Less: current portion
Long-term portion, net of unamortized discounts of $34,194 and 36,331	$ 25,806	$ 23,669

XML

NOTE 2 GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Accumulated deficit	$ (3,619,669)		$ (3,331,878)
Working Capital	98,811
Successor [Member]
Net loss	$ (287,791)
Predecessor [Member]
Net loss		$ (72,022)

XML

NOTE 4 - PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Successor [Member]
Depreciation expense	$ 3,859
Predecessor [Member]
Depreciation expense		$ 5,100

XML

NOTE 7 - RELATED PARTY DEBT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2016
Related Party Transactions [Abstract]
Promissory Note for cash amount	$ 60,000
Interest rate on promissory note	10.00%
First payment due date	Mar. 31, 2015
Loan maturity date	Mar. 31, 2020
Amount to be raised that will make the entire balance of the note due immediately	$ 2,000,000
Number of Series B preferred sshares equity payment issued with debt	53,073
The relative fair value of the Series B preferred stock recorded as debt discount		$ 42,742
Remaining balance of this note	$ 60,000
Net of the unamortized discount		$ 25,806

XML

Disclosure - NOTE 8 - COMMITMENTS AND CONTINGENCIES (Details Narrative)	Dec. 31, 2015 USD ($)
Disclosure - Note 8 - Commitments And Contingencies Details Narrative
2016	$ 25,155
2017	34,379
2018	35,410
2019	$ 15,093
2020
Total	$ 110,037

XML

Disclosure - NOTE 8 - COMMITMENTS AND CONTINGENCIES (Details Narrative2) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Successor [Member]
Rent Expense	$ 7,589
Predecessor [Member]
Rent Expense		$ 6,435

XML

Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (Details Narrative) - $ / shares

3 Months Ended

Mar. 31, 2016

Dec. 31, 2015

Preferred stock terms of conversion

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock, each having a par value of $0.001, with voting, distribution, dividend and redemption rights, and liquidation preferences and conversions as designated by the board of directors.  The board of directors has designated 250,000 shares as Series A Preferred stock, par value $.001 per share ("Series A Preferred").  Each share of Series A Preferred shall have 500 votes for any election or other vote placed before the shareholders of the Company.  As of March 31, 2016, 250,000 shares of Series A Preferred are issued and outstanding.  The board of directors has designated 300,000 shares as Series B Preferred stock, par value $.001 per shares ("Series B Preferred").  The Series B Preferred is non-voting, not eligible for dividends and ranks equal to common stock and below Series A preferred stock.  Each share of Series B Preferred has a conversion rate into eight shares of common stock.  As of March 31, 2016, 254,807 shares of Series B Preferred are issued and outstanding.

Preferred Shares authorized to be Issued

250,000

250,000

Par Value

$ 0.001

$ 0.001

Common stock issuance and terms of conversion

Common Stock

There were no new issuances of common stock during the three months ended March 31, 2016.  As of March 31, 2016, 15,435,651 shares of common stock are issued and outstanding.

Number of common shares authorized to issue

50,000,000

Series A Preferred Stock [Member]

Preferred Shares authorized to be Issued

250,000

Par Value

$ 0.001

Series B Preferred Stock [Member]

Preferred Shares authorized to be Issued

300,000

Par Value

$ 0.001

XML

NOTE 10 - COMMON STOCK WARRANTS (Details Narrative) - $ / shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Shares
Outstanding, Beginning Balance	1,127,000	0.94
Granted	100,000	0.40
Outstanding, Ending Balance	1,127,000	0.90
Weighted Average Exercise Price
Outstanding, Ending Balance	$ 1,127,000	$ 0.90